Matrix adjuvants and the drop pills prepared with them

Details for Australian Patent Application No. 2004253211 (hide)

Owner Tianjin Tasly Pharmaceutical Co., Ltd., China

Inventors Zhu, Guoguang; Yan, Xijun; Lu, Wenliang; Ye, Zhengliang; Wang, Shuangming; Chen, Jianming; Wang, Wei; Zhu, Yonghong; Yang, Yuewu; Zheng, Zhigang

Agent Griffith Hack

Pub. Number AU-B-2004253211

PCT Pub. Number WO2005/002547

Priority 200410018761.6 17.03.04 CN; 03145615.4 02.07.03 CN

Filing date 2 July 2004

Wipo publication date 13 January 2005

Acceptance publication date 17 September 2009

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 47/00 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 47/36 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

A61K 47/40 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cyclodextrins

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2005/002547 Priority application(s): WO2005/002547

23 March 2006 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 01 Mar 2006

17 September 2009 Application Accepted

  Published as AU-B-2004253211

21 January 2010 Standard Patent Sealed

2 August 2012 Application for Amendment

  The nature of the amendment is: Amend the patentee name to read Tasly Pharmaceutical Group ., Ltd. . Address for service in Australia - Griffith Hack GPO Box 1285 Melbourne VIC 3001

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004253225-The combination of a serotonin reuptake inhibitors and agomelatine

2004253197-Membrane post treatment